Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Comparative effects of sibutramine and orlistat on weight loss, glucose metabolism and leptin levels in non-diabetic obese patients: A prospective study.

Anagnostis P, Selalmatzidou D, Sapranidis M, Panagiotou A, Polyzos SA, Slavakis A, Kita M.

Indian J Endocrinol Metab. 2012 Jan;16(1):146-7. doi: 10.4103/2230-8210.91214. No abstract available.

2.

[Prevalence of metabolic syndrome and its components in patients with acute coronary syndrome].

Jover A, Corbella E, Muñoz A, Millán J, Pintó X, Mangas A, Zúñiga M, Pedro-Botet J, Hernández-Mijares A.

Rev Esp Cardiol. 2011 Jul;64(7):579-86. doi: 10.1016/j.recesp.2011.03.010. Epub 2011 Jun 2. Spanish.

3.

A pilot study of the Spanish Ketogenic Mediterranean Diet: an effective therapy for the metabolic syndrome.

Pérez-Guisado J, Muñoz-Serrano A.

J Med Food. 2011 Jul-Aug;14(7-8):681-7. doi: 10.1089/jmf.2010.0137. Epub 2011 May 25.

PMID:
21612461
4.

Prevalence of metabolic syndrome according to different definitions in a hypertensive population.

Lioudaki E, Vrentzos GE, Mavrogeni H, Zeniodi MH, Ganotakis ES, Mikhailidis DP, Papadakis JA.

Angiology. 2012 Jan;63(1):39-47. doi: 10.1177/0003319711407303. Epub 2011 May 8.

PMID:
21555311
5.

Metabolic syndrome and pancreatic cancer risk: a case-control study in Italy and meta-analysis.

Rosato V, Tavani A, Bosetti C, Pelucchi C, Talamini R, Polesel J, Serraino D, Negri E, La Vecchia C.

Metabolism. 2011 Oct;60(10):1372-8. doi: 10.1016/j.metabol.2011.03.005. Epub 2011 May 6.

PMID:
21550085
6.

Metabolic syndrome and chronic kidney disease in high-risk Italian hypertensive patients: the I-DEMAND study.

Leoncini G, Viazzi F, Agabiti Rosei E, Ambrosioni E, Costa FV, Leonetti G, Pessina AC, Trimarco B, Volpe M, Deferrari G, Pontremoli R.

J Nephrol. 2012 Jan-Feb;25(1):63-74. doi: 10.5301/JN.2011.7752.

PMID:
21534241
7.

Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting.

Piccinni C, Motola D, Marchesini G, Poluzzi E.

Diabetes Care. 2011 Jun;34(6):1369-71. doi: 10.2337/dc10-2412. Epub 2011 Apr 22.

8.

Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): a prospective-randomized study in middle aged men and women.

Athyros VG, Ganotakis E, Kolovou GD, Nicolaou V, Achimastos A, Bilianou E, Alexandrides T, Karagiannis A, Paletas K, Liberopoulos EN, Tziomalos K, Petridis D, Kakafika A, Elisaf MS, Mikhailidis DP; Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT) Collaborative.

Curr Vasc Pharmacol. 2011 Nov;9(6):647-57.

PMID:
21476961
9.

Pioglitazone for diabetes prevention in impaired glucose tolerance.

DeFronzo RA, Tripathy D, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Clement SC, Henry RR, Hodis HN, Kitabchi AE, Mack WJ, Mudaliar S, Ratner RE, Williams K, Stentz FB, Musi N, Reaven PD; ACT NOW Study.

N Engl J Med. 2011 Mar 24;364(12):1104-15. doi: 10.1056/NEJMoa1010949. Erratum in: N Engl J Med. 2011 Jul 14;365(2):189. N Engl J Med. 2011 Sep 1;365(9):869.

10.

Why not use the HbA1c as a criterion of dysglycemia in the new definition of the metabolic syndrome? Impact of the new criteria in the prevalence of the metabolic syndrome in a Mediterranean urban population from Southern Europe (IMAP study. Multidisciplinary intervention in primary care).

Bernal-Lopez MR, Villalobos-Sanchez A, Mancera-Romero J, Jansen-Chaparro S, Baca-Osorio AJ, Lopez-Carmona MD, Tinahones FJ, Gomez-Huelgas R.

Diabetes Res Clin Pract. 2011 Aug;93(2):e57-60. doi: 10.1016/j.diabres.2011.02.024. Epub 2011 Mar 21.

PMID:
21420192
11.

Metabolic syndrome and the risk of breast cancer in postmenopausal women.

Rosato V, Bosetti C, Talamini R, Levi F, Montella M, Giacosa A, Negri E, La Vecchia C.

Ann Oncol. 2011 Dec;22(12):2687-92. doi: 10.1093/annonc/mdr025. Epub 2011 Mar 17.

PMID:
21415236
12.

Prevalence of metabolic syndrome and cardiovascular disease in a hypertriglyceridemic population.

Ascaso JF, Millán J, Mateo-Gallego R, Ruiz A, Suarez-Tembra M, Borrallo RM, Zambon D, Gonzalez-Santos P, Peres-de-Juan M, Ros E; Hypertriglyceridemia Registry of Spanish Arteriosclerosis Society.

Eur J Intern Med. 2011 Apr;22(2):177-81. doi: 10.1016/j.ejim.2010.12.011. Epub 2011 Jan 14.

PMID:
21402249
13.

Relationship between nonalcoholic fatty liver disease and metabolic syndrome.

Chen SH, He F, Zhou HL, Wu HR, Xia C, Li YM.

J Dig Dis. 2011 Apr;12(2):125-30. doi: 10.1111/j.1751-2980.2011.00487.x.

PMID:
21401898
14.

Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus: a randomized controlled trial: the Italian Diabetes and Exercise Study (IDES).

Balducci S, Zanuso S, Nicolucci A, De Feo P, Cavallo S, Cardelli P, Fallucca S, Alessi E, Fallucca F, Pugliese G; Italian Diabetes Exercise Study (IDES) Investigators.

Arch Intern Med. 2010 Nov 8;170(20):1794-803. doi: 10.1001/archinternmed.2010.380.

PMID:
21059972
15.

Long-term efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in hyperlipidaemic patients with diabetes or metabolic syndrome.

Fazio S, Guyton JR, Lin J, Tomassini JE, Shah A, Tershakovec AM.

Diabetes Obes Metab. 2010 Nov;12(11):983-93. doi: 10.1111/j.1463-1326.2010.01289.x.

PMID:
20880345
16.

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.

James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP, Torp-Pedersen C, Sharma AM, Shepherd GM, Rode RA, Renz CL; SCOUT Investigators.

N Engl J Med. 2010 Sep 2;363(10):905-17. doi: 10.1056/NEJMoa1003114.

17.

Testosterone and metabolic syndrome: a meta-analysis study.

Corona G, Monami M, Rastrelli G, Aversa A, Tishova Y, Saad F, Lenzi A, Forti G, Mannucci E, Maggi M.

J Sex Med. 2011 Jan;8(1):272-83. doi: 10.1111/j.1743-6109.2010.01991.x. Epub 2010 Aug 30. Review.

PMID:
20807333
18.

Pleiotropic effects of atorvastatin and fenofibrate in metabolic syndrome and different types of pre-diabetes.

Krysiak R, Gdula-Dymek A, Bachowski R, Okopien B.

Diabetes Care. 2010 Oct;33(10):2266-70. doi: 10.2337/dc10-0272. Epub 2010 Jun 29.

19.

Metabolic syndrome: clinical and angiographic impact on patients with acute coronary syndrome.

Miller AM, Alcaraz Ruiz A, Borrayo Sánchez G, Almeida Gutiérrez E, Vargas Guzmán RM, Jáuregui Aguilar R.

Cir Cir. 2010 Mar-Apr;78(2):113-20. English, Spanish.

PMID:
20478111
20.

Prevalence of metabolic syndrome with International Diabetes Federation Criteria and ATP III Program in patients 65 years of age or older.

De Luis DA, Lopez Mongil R, Gonzalez Sagrado M, Lopez Trigo JA, Mora PF, Castrodeza Sanz J; Group Novomet.

J Nutr Health Aging. 2010 May;14(5):400-4.

PMID:
20424809

Supplemental Content

Support Center